Cargando…

Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]

INTRODUCTION: Some guidelines to prevent ventilator-associated pneumonia (VAP) do not establish a recommendation for the preferential use of either heat and moisture exchangers (HMEs) or heated humidifiers (HHs), while other guidelines clearly advocate the use of HMEs. The aim of this study was to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorente, Leonardo, Lecuona, María, Jiménez, Alejandro, Mora, María L, Sierra, Antonio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750976/
https://www.ncbi.nlm.nih.gov/pubmed/16884530
http://dx.doi.org/10.1186/cc5009
_version_ 1782131397842960384
author Lorente, Leonardo
Lecuona, María
Jiménez, Alejandro
Mora, María L
Sierra, Antonio
author_facet Lorente, Leonardo
Lecuona, María
Jiménez, Alejandro
Mora, María L
Sierra, Antonio
author_sort Lorente, Leonardo
collection PubMed
description INTRODUCTION: Some guidelines to prevent ventilator-associated pneumonia (VAP) do not establish a recommendation for the preferential use of either heat and moisture exchangers (HMEs) or heated humidifiers (HHs), while other guidelines clearly advocate the use of HMEs. The aim of this study was to determine the incidence of VAP associated with HHs or HMEs. METHODS: A randomized study was conducted in the intensive care unit of a university hospital involving patients expected to require mechanical ventilation for >5 days. Patients were assigned to two groups; one group received HH and the other group received HME. Tracheal aspirate samples were obtained on endotracheal intubation, then twice a week, and finally on extubation, in order to diagnose VAP. Throat swabs were taken on admission to the intensive care unit, then twice a week, and finally at discharge from the intensive care unit in order to classify VAP as primary endogenous, secondary endogenous, or exogenous. RESULTS: A total of 120 patients were assigned to HMEs (60 patients) and HHs (60 patients); 16 patients received mechanical ventilation for less than five days and were excluded from the analysis. Data analysis of the remaining 104 patients (53 HMEs and 51 HHs) showed no significant differences between groups regarding sex, age, Acute Physiology and Chronic Health Evaluation II score, pre-VAP use of antibiotics, days on mechanical ventilation, and diagnosis group. VAP was found in eight of 51 (15.69%) patients in the HH group and in 21 of 53 (39.62%) patients in the HME group (P = 0.006). The median time free of VAP was 20 days (95% confidence interval, 13.34–26.66) for the HH group and was 42 days (95% confidence interval, 35.62–48.37) for the HME group (P <0.001). Cox regression analysis showed the HME as a risk factor for VAP (hazard rate, 16.2; 95% confidence interval, 4.54–58.04; P < 0.001). CONCLUSION: The patients mechanically ventilated for more than five days developed a lower incidence of VAP with a HH than with a HME.
format Text
id pubmed-1750976
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17509762006-12-27 Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583] Lorente, Leonardo Lecuona, María Jiménez, Alejandro Mora, María L Sierra, Antonio Crit Care Research INTRODUCTION: Some guidelines to prevent ventilator-associated pneumonia (VAP) do not establish a recommendation for the preferential use of either heat and moisture exchangers (HMEs) or heated humidifiers (HHs), while other guidelines clearly advocate the use of HMEs. The aim of this study was to determine the incidence of VAP associated with HHs or HMEs. METHODS: A randomized study was conducted in the intensive care unit of a university hospital involving patients expected to require mechanical ventilation for >5 days. Patients were assigned to two groups; one group received HH and the other group received HME. Tracheal aspirate samples were obtained on endotracheal intubation, then twice a week, and finally on extubation, in order to diagnose VAP. Throat swabs were taken on admission to the intensive care unit, then twice a week, and finally at discharge from the intensive care unit in order to classify VAP as primary endogenous, secondary endogenous, or exogenous. RESULTS: A total of 120 patients were assigned to HMEs (60 patients) and HHs (60 patients); 16 patients received mechanical ventilation for less than five days and were excluded from the analysis. Data analysis of the remaining 104 patients (53 HMEs and 51 HHs) showed no significant differences between groups regarding sex, age, Acute Physiology and Chronic Health Evaluation II score, pre-VAP use of antibiotics, days on mechanical ventilation, and diagnosis group. VAP was found in eight of 51 (15.69%) patients in the HH group and in 21 of 53 (39.62%) patients in the HME group (P = 0.006). The median time free of VAP was 20 days (95% confidence interval, 13.34–26.66) for the HH group and was 42 days (95% confidence interval, 35.62–48.37) for the HME group (P <0.001). Cox regression analysis showed the HME as a risk factor for VAP (hazard rate, 16.2; 95% confidence interval, 4.54–58.04; P < 0.001). CONCLUSION: The patients mechanically ventilated for more than five days developed a lower incidence of VAP with a HH than with a HME. BioMed Central 2006 2006-08-02 /pmc/articles/PMC1750976/ /pubmed/16884530 http://dx.doi.org/10.1186/cc5009 Text en Copyright © 2006 Lorente et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lorente, Leonardo
Lecuona, María
Jiménez, Alejandro
Mora, María L
Sierra, Antonio
Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]
title Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]
title_full Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]
title_fullStr Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]
title_full_unstemmed Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]
title_short Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]
title_sort ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [isrctn88724583]
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750976/
https://www.ncbi.nlm.nih.gov/pubmed/16884530
http://dx.doi.org/10.1186/cc5009
work_keys_str_mv AT lorenteleonardo ventilatorassociatedpneumoniausingaheatedhumidifieroraheatandmoistureexchangerarandomizedcontrolledtrialisrctn88724583
AT lecuonamaria ventilatorassociatedpneumoniausingaheatedhumidifieroraheatandmoistureexchangerarandomizedcontrolledtrialisrctn88724583
AT jimenezalejandro ventilatorassociatedpneumoniausingaheatedhumidifieroraheatandmoistureexchangerarandomizedcontrolledtrialisrctn88724583
AT moramarial ventilatorassociatedpneumoniausingaheatedhumidifieroraheatandmoistureexchangerarandomizedcontrolledtrialisrctn88724583
AT sierraantonio ventilatorassociatedpneumoniausingaheatedhumidifieroraheatandmoistureexchangerarandomizedcontrolledtrialisrctn88724583